Home -> Law Blog Directory -> Patent Law Blogs -> Patent Baristas
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: Patent BaristasIs the USPTO Striking Back With Double Patenting Rejections?
By Stephen Albainy-Jenei
Greg Aharonian at Internet Patent News Service posted note about a possible increase in double-patenting rejections as the U.S. Patent Office. In a complaint he received, a reader questions whether this is an orchestrated implementation of “directives to frustrate patent applicants to achieve their misguided purpose.”
As an example, the reader noted that the Patent Office seems to be (undeservedly) dishing out more statutory double patenting rejections. Although the example dealt with claims directed to computer readable storage media and accompanying systems and methods, this can also be a problem in the bio/pharma where drug companies are constantly trying to file patent applications on continued changes and improvements in order to capture or retain market share.
Basically, the law provides that an applicant may only obtain a single patent for an invention. 35 USC 101 provides:
Whoever invents or discovers any new and useful process, machine, manufacture, or composition of matter or any new and useful improvement thereof, may obtain a patent therefor, subject to the conditions and requirements of this title.
Thus, a statutory double patenting rejection comes up when the applicant tries to claim the exact same invention. The purpose, of course, is to prevent a patentee from receiving multiple patents for the same invention and thus gaining an illegal extension of patent term. Therefore, a pharmaceutical company can only be able to prevent generic entry for a period of 20 years from the filing date of the application (albeit with certain extensions available).
One quick test of whether or not there’s a problem is to ask:
- Is there an embodiment that falls within the scope of one claim, but not the other?
- Could one claim be literally infringed without literally infringing the other claim?
Since bio & pharma patents seem to be under seige, I’m curious if others have experienced an uptick in statutory-type double patenting rejections?
Let us know.
Full post as published by Patent Baristas on April 23, 2008 (boomark / email).
Digitek Recalled
the heart drug allegedly contains double the medication that it should
Chattanooga, TN
Seven months in back pay resolves pepper spray dispute.
Deja Vu
Exotic Dancers file class action claiming back wages
Canadian Government
former RCMP officer claims thousands of disability dollars clawed back.
Personal Property Taxes
Village of Romeo pays Ford Motor Company a $1.2 million settlement for double charging.
Rutland School District
Double pay offered as part of class action wage dispute settlement, pending court approval.

BPAI: when prior art teaches away, expectation of success cannot support obviousness rejection
Is being pro-active a good thing
Does "culture of rejection" influence patent grant rates at USPTO
C5 Biotech Patenting Conference
USPTO Modifies Declaration to Permit Access to Application by Foreign Patent Offices









